BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16711)

  • 1. Anti-tumour immunity by normal allogeneic blood transfusion in rat.
    Oikawa T; Hosokawa M; Imamura M; Sendo F; Nakayama M
    Clin Exp Immunol; 1977 Mar; 27(3):549-54. PubMed ID: 16711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of syngeneic tumor growth in rats immunized with allogeneic skin grafts.
    Hosokawa M; Imamura M; Oikawa T; Nakayama M; Gotohda E; Sendo F; Kodama T; Kobayashi H
    Int J Cancer; 1976 Sep; 18(3):369-74. PubMed ID: 783054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonspecific inhibition of in vivo tumor growth by allo-sensitized lymphocytes - requirement of radio-sensitive T-lymphocytes.
    Sendo F
    Hokkaido Igaku Zasshi; 1982 Jan; 57(1):27-35. PubMed ID: 6978834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.
    Quigley RL; Wood KJ; Morris PJ
    Immunology; 1988 Mar; 63(3):373-81. PubMed ID: 2965097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation immunity to syngeneic tumors in WKA rats immunized with allogeneic cells.
    Kobayashi H; Hosokawa M; Oikawa T
    Transplant Proc; 1980 Mar; 12(1):156-9. PubMed ID: 6989056
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma.
    Parrott NR; Lennard TW; Proud G; Shenton BK; Givan A; White MD; Taylor R
    Ann R Coll Surg Engl; 1990 Mar; 72(2):77-81. PubMed ID: 2334101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of blood transfusions on rat corneal graft survival.
    Ayliffe W; McLeod D; Hutchinson IV
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1974-8. PubMed ID: 1582802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
    Hosokawa M; Yamashita T; Gotohda E; Takeichi N; Kodama T; Kobayashi H
    Int J Cancer; 1978 Jul; 22(1):91-7. PubMed ID: 681026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total orthotopic allogeneic small bowel transplantation in rats. Attempts to ameliorate the graft-versus-host disease by irradiation and transfusions of the donor.
    Saat RE; Heineman E; de Bruin RW; Marquet RL; Jeekel J
    Transplantation; 1989 Mar; 47(3):451-3. PubMed ID: 2646777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal cell populations during tumour injection.
    De Heer E; De Groot JW; Den Otter W; Dullens HF
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion induces blood donor-specific suppressor cells.
    Quigley RL; Wood KJ; Morris PJ
    J Immunol; 1989 Jan; 142(2):463-70. PubMed ID: 2521347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
    Clark DA; Gorczynski RM; Blajchman MA
    Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for antitumor resistance in WKA rats immunized with allogeneic cells.
    Kobayashi H; Hosokawa M
    Transplant Proc; 1981 Dec; 13(4):1922-6. PubMed ID: 7036483
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of immunomodulation following allogeneic blood transfusion on tumor neogenesis and growth--experimental studies in rats].
    Scholler PM; Zeller WJ; Rössler W; Lenhard V; Weber E; Schmähl D; Dreikorn K
    Arch Geschwulstforsch; 1987; 57(2):81-90. PubMed ID: 3592925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological studies on renal transplantation in rats. Effects of pretransplant blood transfusion on renal graft survival].
    Ueda H
    Hinyokika Kiyo; 1985 Dec; 31(12):2169-82. PubMed ID: 3914214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonspecific inhibition of tumor growth in vivo by admixed allogeneic tumor-sensitized lymphoid cells and identical inactivated allogeneic tumor cells.
    Sendo F; Nakayama M; Gotohda E; Kobayashi
    J Immunol; 1976 Oct; 117(4):1340-5. PubMed ID: 61998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of blood loss on tumour growth: effect and mechanism in an experimental model.
    Hoynck van Papendrecht MA; Busch OR; Jeekel J; Marquet RL
    Neth J Surg; 1991 Aug; 43(4):85-8. PubMed ID: 1944994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.